Loading…
Monkeypox-treatment.com was warned for promoting unapproved new drugs and misbranded products through its website, including over-the-counter medications (Advil, Tylenol, ibuprofen products) and dietary supplements (B12 vitamin, adrenal support) with claims that they could treat, prevent, diagnose, or cure mpox. The company violated the Federal Food, Drug, and Cosmetic Act by earning commissions through an Amazon Associates program to sell these products with therapeutic claims, causing them to be classified as unapproved new drugs under section 505(a) and misbranded drugs under section 502(f)(1). The FDA took this enforcement action during a declared nationwide public health emergency for mpox to protect consumers from unproven remedies.